Answers are grounded in this paper and cite their sources.
Histopathological study evaluates CD14 expression's role in recurrence of breast cancer, suggesting potential implications.
values were (0.002, <0.001 & 0.042) respectively. Peritumoral CD14 positivity was significantly higher in recurrent breast cancer cases (50.9%) than in available primary ones (11.1%). CD14 positivity was higher in recurrent than in primary breast cancer, and its statistically significant association with early recurrence and high Ki67 suggests a potential role in breast cancer progression.
No takes yet. Share an insight, caveat, or question.
Shalaby et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: